Alexandre Vivot

1.1k total citations
29 papers, 745 citations indexed

About

Alexandre Vivot is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alexandre Vivot has authored 29 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alexandre Vivot's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Reproductive Biology and Fertility (3 papers). Alexandre Vivot is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Reproductive Biology and Fertility (3 papers). Alexandre Vivot collaborates with scholars based in France, United States and Switzerland. Alexandre Vivot's co-authors include Philippe Ravaud, Perrine Créquit, Raphaël Porcher, Jean‐David Zeitoun, M. Maria Glymour, Mehdi Benchoufi, Elizabeth Rose Mayeda, Carole Dufouil, Isabelle Boutron and Geneviève Chêne and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Alexandre Vivot

29 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexandre Vivot France	14	127	100	87	78	64	29	745
Laura Pasea United Kingdom	16	73 0.6×	141 1.4×	37 0.4×	132 1.7×	61 1.0×	31	1.4k
Raymond Jang Canada	19	117 0.9×	72 0.7×	136 1.6×	91 1.2×	47 0.7×	44	768
Anthony Matthews Sweden	16	102 0.8×	51 0.5×	85 1.0×	85 1.1×	81 1.3×	44	1.1k
Graham Wheeler United Kingdom	10	164 1.3×	79 0.8×	29 0.3×	125 1.6×	29 0.5×	31	847
Sarah L. Hulin-Curtis United Kingdom	13	178 1.4×	38 0.4×	60 0.7×	91 1.2×	66 1.0×	22	941
Valerie Kuan United Kingdom	13	57 0.4×	70 0.7×	42 0.5×	81 1.0×	38 0.6×	18	753
Iacopo Cricelli Italy	17	98 0.8×	68 0.7×	68 0.8×	34 0.4×	110 1.7×	43	833
Mats Julius Stensrud Switzerland	16	151 1.2×	32 0.3×	36 0.4×	67 0.9×	31 0.5×	64	940
Perrine Janiaud United States	15	153 1.2×	37 0.4×	48 0.6×	131 1.7×	20 0.3×	46	960
Margaret Haugh France	18	141 1.1×	141 1.4×	59 0.7×	262 3.4×	77 1.2×	35	1.3k

Countries citing papers authored by Alexandre Vivot

Since Specialization

Citations

This map shows the geographic impact of Alexandre Vivot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Vivot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Vivot more than expected).

Fields of papers citing papers by Alexandre Vivot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Vivot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Vivot. The network helps show where Alexandre Vivot may publish in the future.

Co-authorship network of co-authors of Alexandre Vivot

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Vivot. A scholar is included among the top collaborators of Alexandre Vivot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Vivot. Alexandre Vivot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Créquit, Perrine, Alexandre Vivot, Jules Grégory, & B. Milleron. (2022). Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries. Journal of Cancer Policy. 33. 100347–100347. 1 indexed citations

Labrosse, Julie, Isabelle Cédrin‐Durnerin, Maëliss Peigné, et al.. (2021). Impact of oxygen tension according to embryo stage of development: a prospective randomized study. Scientific Reports. 11(1). 22313–22313. 13 indexed citations

Vivot, Alexandre, et al.. (2020). Bayesian analysis from phase III trials was underused and poorly reported: a systematic review. Journal of Clinical Epidemiology. 123. 107–113. 6 indexed citations

Vivot, Alexandre, et al.. (2019). A Methodologic Systematic Review of Mobile Health Behavior Change Randomized Trials. American Journal of Preventive Medicine. 57(6). 836–843. 12 indexed citations

Créquit, Perrine, et al.. (2018). Mapping of Crowdsourcing in Health: Systematic Review. Journal of Medical Internet Research. 20(5). e187–e187. 89 indexed citations

Cédrin‐Durnerin, Isabelle, Alexandre Vivot, Charlotte Sonigo, et al.. (2018). Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study. Fertility and Sterility. 110(7). 1290–1297. 9 indexed citations

Vivot, Alexandre, Perrine Créquit, & Raphaël Porcher. (2018). Use of Late-Life Expectancy for Assessing the Long-Term Benefit of Immune Checkpoint Inhibitors. JNCI Journal of the National Cancer Institute. 111(5). 519–521. 6 indexed citations

Créquit, Perrine, et al.. (2018). Living network meta-analysis was feasible when considering the pace of evidence generation. Journal of Clinical Epidemiology. 108. 10–16. 12 indexed citations

Vivot, Alexandre, et al.. (2017). Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015. Annals of Oncology. 28(5). 1111–1116. 92 indexed citations

10.

Boujenah, J., Isabelle Cédrin‐Durnerin, Nathalie Sermondade, et al.. (2017). Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality?. Reproductive BioMedicine Online. 35(5). 521–528. 26 indexed citations

11.

Vivot, Alexandre, et al.. (2017). Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing. Scientific Reports. 7(1). 6882–6882. 21 indexed citations

12.

Vivot, Alexandre, Melinda C. Power, M. Maria Glymour, et al.. (2016). Jump, Hop, or Skip: Modeling Practice Effects in Studies of Determinants of Cognitive Change in Older Adults. American Journal of Epidemiology. 183(4). 302–314. 85 indexed citations

13.

Vivot, Alexandre, M. Maria Glymour, Christophe Tzourio, et al.. (2015). Association of Alzheimer’s related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study. Molecular Psychiatry. 20(10). 1173–1178. 31 indexed citations

14.

Sibon, Igor, Thomas Tourdias, Sandra Felix, et al.. (2015). Magnetisation transfer parameters and stroke outcome. Journal of Clinical Neuroscience. 22(6). 1012–1017. 9 indexed citations

15.

Vivot, Alexandre, Jean‐David Zeitoun, Samia Mourah, et al.. (2015). Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov. Genetics in Medicine. 18(8). 796–805. 7 indexed citations

16.

Vivot, Alexandre, Isabelle Boutron, Philippe Ravaud, & Raphaël Porcher. (2014). Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs. Genetics in Medicine. 17(9). 733–738. 31 indexed citations

17.

Asselineau, Julien, Paul Perez, Alexandre Vivot, et al.. (2014). Accuracy of repeated measurements of late‐night salivary cortisol to screen for early‐stage recurrence of Cushing's disease following pituitary surgery. Clinical Endocrinology. 82(2). 260–266. 29 indexed citations

18.

Vivot, Alexandre, et al.. (2013). Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus. Diabetes & Metabolism. 39(4). 349–354. 49 indexed citations

19.

Ghorayeb, Imad, Antoine Bénard, Alexandre Vivot, François Tison, & Pierre Burbaud. (2012). A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome. Sleep Medicine. 13(10). 1313–1316. 12 indexed citations

20.

Larrouy, Lucile, Alexandre Vivot, Charlotte Charpentier, et al.. (2012). Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients. AIDS. 27(1). 69–80. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact